Market will ascribe value long before we get “the tick”, imo.
Once the weak hands have been shaken out we’ll be ready for the next run. Its setting up nicely.
BMS Lag3 Relatlimab approval early 2022 will be next big inflection point, imo. Astute investors would want to be on board before then.
- Forums
- ASX - By Stock
- Ann: Immutep Global Webcast Slides to Discuss Clinical Results
Market will ascribe value long before we get “the tick”,...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
42.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $598.3M |
Open | High | Low | Value | Volume |
41.5¢ | 42.5¢ | 41.0¢ | $1.132M | 2.721M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 15565 | 41.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
42.5¢ | 246989 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 15565 | 0.415 |
4 | 230569 | 0.410 |
4 | 34436 | 0.405 |
7 | 45918 | 0.400 |
5 | 169711 | 0.395 |
Price($) | Vol. | No. |
---|---|---|
0.425 | 246989 | 7 |
0.430 | 110012 | 6 |
0.435 | 60064 | 4 |
0.440 | 57636 | 5 |
0.445 | 27000 | 3 |
Last trade - 16.10pm 25/06/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |